78 %
Results
Changing Lives — With Proven, Measurable Outcomes For patients with drug-resistant major depression, NeuroStar® TMS delivers outcomes that traditional treatments often can’t. Backed by robust clinical data — including the world’s largest depression Outcomes Registry** — NeuroStar provides the proven results your practice can rely on.
Proven Depression Relief That Lasts
Safe and Effective for Adolescent Depression
Only two antidepressants are currently FDA-approved for adolescents, and many teens either do not respond or cannot tolerate medication. NeuroStar offers first-line, adjunct treatment option that is proven and non-invasive – giving providers another path to relief for their adolescent patients who need additional support.
NeuroStar has delivered over 400,000 treatment sessions to over 13,000 adolescents, providing practices with confidence grounded in extensive real-world experience and outcomes.
(Data on File, 2026)
Proven Results in Adolescents
48 %
More Clinical Data than Any Other TMS Provider
Real-World Trials
NeuroStar’s safety and efficacy is backed by the largest clinical data set of any TMS system for depression.2 The clinically significant antidepressant effect of NeuroStar Advanced Therapy was demonstrated in two large, multisite, randomized, controlled trials.11,19NeuroStar’s efficacy was also demonstrated in a multisite, real-world, open-label clinical trial in which patients received an acute NeuroStar treatment course.7,11,12,15,17,19
4x Remission Rate
Clinical results demonstrated an improvement in depression symptoms. In an NIMH-funded, independent, randomized, controlled trial, patients treated with NeuroStar Advanced Therapy were four times more likely to achieve remission compared to patients receiving sham treatment.11 Significant improvement from baseline with NeuroStar Advanced Therapy was observed as early as 2 weeks after treatment and at 4 and 6 weeks (P=0.0006).4
17,700+ Patients
Only the NeuroStar® Advanced Therapy Outcomes Registry has data on over 17,700 patients since being initiated in September 2016, making it the largest data set in major depressive disorder. This data is from 118 NeuroStar practice sites.2,6,22
65 Clinical Studies
NeuroStar’s commitment to advancing the science of TMS and neurohealth has been demonstrated in over 65 investigator-initiated clinical studies with more than 1,900 patients.
If you’re interested in conducting an Investigator Initiated Trial, please contact Neuronetics Customer Service at 877-600-7555.
Numerous Publications
NeuroStar is proven in scientific publicati ons and presentations. Click here for links to publications related to the safety and efficacy of NeuroStar Advanced Therapy.
Numerous Publications
NeuroStar is proven in scientific publications and presentations. Click here for links to publications related to the safety and efficacy of NeuroStar Advanced Therapy.
NeuroStar Clinical Playbook
Explore the data. Discover the potential.
Get your copy of the NeuroStar Clinical Playbook
The Best Evidence Is a Changed Life
MDD patients often go through years of trial and error with different medications. For those people, the life-changing power of NeuroStar can best be grasped through their own words.
MLB’s Drew Robinson — a TMS Journey
Drew Robinson had reached the peak, playing baseball at the highest level, but inside Drew was suffering. He thought he was out of options, and tried to take his own life.
Drew's NeuroStar JourneyJoin the NeuroStar Community
